A Double-blind, Randomized, Placebo and Naproxen Controlled Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386, in Patients Undergoing Impacted Mandibular Third Molar Extraction.

Trial Profile

A Double-blind, Randomized, Placebo and Naproxen Controlled Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386, in Patients Undergoing Impacted Mandibular Third Molar Extraction.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2015

At a glance

  • Drugs AZD 1386 (Primary) ; Naproxen
  • Indications Dental pain; Postoperative pain
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 02 Sep 2010 Results were reported at the 13th World Congress on Pain.
    • 09 Jul 2008 Actual patient number is 103 as reported by ClinicalTrials.gov.
    • 09 Jul 2008 Actual study completion date is now 1 Jun 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top